Top Five Articles on 360Dx Last Week: FDA LDT Rule's Effect on Dx Firms; FDA Clearances; More

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five:

1) It's Not Just Labs. FDA Oversight of LDTs Likely to Impact IVD Vendors Also

2) Abbott, QuidelOrtho, Werfen, Others Gain 510(k) Clearances in August

3) Labcorp Acquires Outreach Lab Assets of Tennessee-Based Ballad Health

4) Roche, Stratipath Ink Deal to Distribute Breast Cancer Digital Pathology Solution

5) Inflammatix Raises $57M in Series E Financing